- Broad spectrum antibacterial agent with activity against a wide range of Gram-positive and Gram-negative bacteria and a typical organisms
- High microbiological eradication rates, ranging from 79.8% to 95.3%
- Shows overall response rate 86% in treatment of acute exacerbation of chronic bronchitis
- Offers combination of documented efficacy and tolerability




